Categories: HardwareITPlatform
Mitrassist is a leading angiocarpy treatment devices platform with globally cutting-edge innovation. It has introduced a minimally invasive approach to Mitral Regurgitation (MR) treatment that is neither repair nor replacement. The company’s “valve-in-valve” approach overcomes the various challenges of MR and offers an improved treatment solution for all MR patients.
Investors 2
Funding Rounds 1
| Date | Series | Amount | Investors |
| 28.09.2023 | Series C | $100M | - |
Mentions in press and media 2
| Date | Title | Description |
| 28.09.2023 | Chinese Cardiovascular Medical Device Maker MitrAssist Bags USD100 Million in Series C Fundraiser | (Yicai) Sept. 28 -- MitrAssist, a Chinese innovative cardiovascular medical device maker, has raised USD100 million in its latest financing round.
The Series C fundraiser was led by Centurium Capital and Tonghe Yucheng, the Shanghai-based c... |
| 01.07.2013 | MitrAssist Raises $1M |
TEL AVIV, ISRAEL, Portfolio company of The Trendlines Group's Misgav Venture Accelerator, recently completed a raise of $1 million from angel investors and a multinational private strategic investor.
>> Click here for more funding ... |
Reviews 0
